La Renon competitors

La Renon Competitors include Hedgepath Pharmaceuticals, India Globalization Capital, Innovation Pharmaceuticals and Alexion Pharmaceuticals.
Add company...
La Renon
An Indian Pharma House with the motto of Creating a Healthy World converting Science into high end formulations for Chronic illnesses and diseases.
Hedgepath Pharmaceuticals
HedgePath Pharma is a clinical stage biopharma company that discovers, develops & plans to commercialize innovative therapeutics for patients with cancer.
India Globalization Capital
India Globalization Capital develops intellectual property for the treatment of life altering or life threatening conditions, through its research on phytocannabinoid-based therapies, in the United States.
Innovation Pharmaceuticals
Innovation Pharmaceuticals is engaged in developing therapies with oncology, dermatology and antimicrobial applications.
Alexion Pharmaceuticals
Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases.
Founding Date
Founding Date
2007
Founding Date
1992
Founding Date
2005
Founding Date
2007
Founding Date
1992
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Ahmedabad, IN HQ
Locations
Tampa, US HQ
Locations
Bethesda, US HQ
Locations
Beverly, US HQ
Locations
New Haven, US HQ
Buenos Aires, AR
Sydney, AU
Vienna, AT
Brussels, BE
São Paulo, BR
Toronto, CA
see more
Employees
Employees
3751% increase
Employees
9
Employees
31
Employees
15
Employees
2,525
Valuation ($)
Valuation ($)
N/A
Valuation ($)
5.2 m
Valuation ($)
90.5 m
Valuation ($)
38.9 m
Valuation ($)
27.5 b
Facebook likes
Facebook likes
7.2 k
Facebook likes
N/A
Facebook likes
1.2 k
Facebook likes
276
Facebook likes
N/A
Twitter followers
Twitter followers
138
Twitter followers
57
Twitter followers
748
Twitter followers
201
Twitter followers
1.8 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$2.2m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
$3.1b (FY, 2016)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$2.1m (FY, 2018)
Cost of goods
N/A
Cost of goods
$258m (FY, 2016)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$81.5k (FY, 2018)
Gross profit
N/A
Gross profit
$2.8b (FY, 2016)
Net income
Net income
N/A
Net income
($5.1m) (FY, 2017)
Net income
($1.8m) (FY, 2018)
Net income
($16.4m) (FY, 2018)
Net income
$399m (FY, 2016)
For sources of this data, please see the company profileDownload Excel

View company profiles

Hedgepath Pharmaceuticals
HQ
Tampa, US
Employees
9

HedgePath Pharma is a clinical stage biopharma company that discovers, develops & plans to commercialize innovative therapeutics for patients with cancer.

View company
India Globalization Capital
HQ
Bethesda, US
Employees
31

India Globalization Capital develops intellectual property for the treatment of life altering or life threatening conditions, through its research on phytocannabinoid-based therapies, in the United States.

View company
Innovation Pharmaceuticals
HQ
Beverly, US
Employees
15

Innovation Pharmaceuticals is engaged in developing therapies with oncology, dermatology and antimicrobial applications.

View company
Alexion Pharmaceuticals
HQ
New Haven, US
Employees
2,525

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases.

View company